JP2016530242A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016530242A5 JP2016530242A5 JP2016526988A JP2016526988A JP2016530242A5 JP 2016530242 A5 JP2016530242 A5 JP 2016530242A5 JP 2016526988 A JP2016526988 A JP 2016526988A JP 2016526988 A JP2016526988 A JP 2016526988A JP 2016530242 A5 JP2016530242 A5 JP 2016530242A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- compound according
- acceptable salt
- hydrogen
- tuberculosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3196CH2013 | 2013-07-17 | ||
| IN3196/CHE/2013 | 2013-07-17 | ||
| PCT/US2014/046100 WO2015009525A1 (en) | 2013-07-17 | 2014-07-10 | Azaindole compounds, synthesis thereof, and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016530242A JP2016530242A (ja) | 2016-09-29 |
| JP2016530242A5 true JP2016530242A5 (enExample) | 2017-08-17 |
| JP6366709B2 JP6366709B2 (ja) | 2018-08-01 |
Family
ID=51261257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016526988A Active JP6366709B2 (ja) | 2013-07-17 | 2014-07-10 | アザインドール化合物、その合成、および同化合物の使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9163020B2 (enExample) |
| EP (1) | EP3021947B1 (enExample) |
| JP (1) | JP6366709B2 (enExample) |
| KR (1) | KR102301753B1 (enExample) |
| CN (1) | CN105636646B (enExample) |
| AU (1) | AU2014290598B2 (enExample) |
| CA (1) | CA2918487C (enExample) |
| EA (1) | EA028611B1 (enExample) |
| ES (1) | ES2644025T3 (enExample) |
| WO (1) | WO2015009525A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201512197A (zh) * | 2013-08-30 | 2015-04-01 | Hoffmann La Roche | 吡咯并吡啶或吡唑并吡啶衍生物 |
| GB201317363D0 (en) * | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
| US11173113B2 (en) | 2017-12-06 | 2021-11-16 | Prollergy Corporation | Composition and method for reducing allergic response |
| RU2702224C2 (ru) * | 2018-03-29 | 2019-10-07 | Общество С Ограниченной Ответственностью "Мт-Медикалс" | Производные фенил формамидина, обладающие антимикобактериальной активностью |
| KR20210021042A (ko) * | 2018-06-15 | 2021-02-24 | 카딜라 핼쓰캐어 리미티드 | 포유동물 감염 치료를 위한 신규한 화합물 |
| WO2020188405A1 (en) * | 2019-03-20 | 2020-09-24 | Foundation For Neglected Disease Research | Benzimidazoles derivatives as anti-tuberculosis agents |
| CN111393435A (zh) * | 2020-03-16 | 2020-07-10 | 青岛吉澳医药科技有限公司 | 氮杂吲哚酰胺类化合物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| BRPI0812594A2 (pt) * | 2007-08-10 | 2015-06-23 | Lundbeck & Co As H | Composto ou sal ou hidrato do mesmo, composição farmacêutica, métodos para modulação da atividade de um receptor p2x7, para tratamento de uma condição responsiva á modulação do receptor p2x7 em um paciente, para inibição de morte de células gangliônicas retinais em um paciente, para determinação da presença ou ausência de receptor p2x7 em uma amostra, preparação farmacêutica acondicionada, e, uso de um composto ou sal ou hidrato do mesmo. |
| MX345762B (es) * | 2010-03-18 | 2017-02-15 | Pasteur Institut Korea | Compuestos antiinfecciosos. |
-
2014
- 2014-07-10 KR KR1020167004150A patent/KR102301753B1/ko active Active
- 2014-07-10 AU AU2014290598A patent/AU2014290598B2/en active Active
- 2014-07-10 EA EA201690227A patent/EA028611B1/ru unknown
- 2014-07-10 WO PCT/US2014/046100 patent/WO2015009525A1/en not_active Ceased
- 2014-07-10 CN CN201480046182.4A patent/CN105636646B/zh active Active
- 2014-07-10 US US14/327,784 patent/US9163020B2/en active Active
- 2014-07-10 EP EP14745305.4A patent/EP3021947B1/en active Active
- 2014-07-10 ES ES14745305.4T patent/ES2644025T3/es active Active
- 2014-07-10 JP JP2016526988A patent/JP6366709B2/ja active Active
- 2014-07-10 CA CA2918487A patent/CA2918487C/en active Active